Finally, the overexpression of a member of the protein kinase C family, PKCβ, involved in signal transduction of growth factors and BCR and known to be a PI3K-independent AKT activator, correlates with poor-prognosis in CLL patients. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.